HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcome of esophageal atresia/tracheoesophageal fistula in extremely low birth weight neonates (<1000 grams).

AbstractPURPOSE:
To review the outcomes of extremely low birth weight (ELBW, <1000 g) infants with esophageal atresia/tracheoesophageal fistula (EA/TEF).
METHODS:
Health records of ELBW EA/TEF infants treated at our institution from 2000 to 2014 were reviewed (REB1000046653). Demographics, operative approach and postoperative complications were analyzed. Data are reported as median (range).
RESULTS:
Of 268 EA/TEF infants, 8 (3 %, five females) were ELBW (930 g, 540-995). Gestational age was 28 weeks (23-32). Seven had type-C EA/TEF and one type B.
OUTCOMES:
One trisomy 18 infant received no treatment and died; one initially diagnosed as type A had primary repair at 126 days of life (DOL); six underwent TEF ligation (three trans-pleural) with primary repair in one and delayed anastomosis in two (DOL 120 and 178). The remaining three died (gastrostomy dehiscence and peritonitis, liver hemorrhage during peritoneal drain insertion, severe chronic lung disease and brain hemorrhages). At a median follow-up of 3 years (range 15 months-5 years), all survivors are thriving.
CONCLUSION:
ELBW infants with EA/TEF are rare and result in high morbidity and mortality. Mortality is mainly related to complications not associated with EA/TEF repair. Fistula ligation followed by delayed anastomosis seems to achieve a better outcome in ELBW infants.
AuthorsAugusto Zani, Justyna Wolinska, Giovanni Cobellis, Priscilla P L Chiu, Agostino Pierro
JournalPediatric surgery international (Pediatr Surg Int) Vol. 32 Issue 1 Pg. 83-8 (Jan 2016) ISSN: 1437-9813 [Electronic] Germany
PMID26519042 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Anastomosis, Surgical
  • Esophageal Atresia (epidemiology, surgery)
  • Female
  • Follow-Up Studies
  • Humans
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Male
  • Postoperative Complications (epidemiology)
  • Survival Analysis
  • Tracheoesophageal Fistula (epidemiology, surgery)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: